These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
341 related articles for article (PubMed ID: 17296397)
1. Safety and tolerability of sedation-free flexible cystoscopy for intradetrusor botulinum toxin-A injection. Cohen BL; Rivera R; Barboglio P; Gousse A J Urol; 2007 Mar; 177(3):1006-10; discussion 1010. PubMed ID: 17296397 [TBL] [Abstract][Full Text] [Related]
2. [Prospective study of the clinical and urodynamic results of intradetrusor botulinum toxin injections for the treatment of neurogenic overactive bladder]. Bentaleb Y; Castel-Lacanal E; Sallusto F; De Boissezon X; Malavaud B; Marque P; Rischmann P; Gamé X Prog Urol; 2008 Jul; 18(7):449-55. PubMed ID: 18602606 [TBL] [Abstract][Full Text] [Related]
3. Botulinum toxin type a injections into the trigone to treat idiopathic overactive bladder do not induce vesicoureteral reflux. Karsenty G; Elzayat E; Delapparent T; St-Denis B; Lemieux MC; Corcos J J Urol; 2007 Mar; 177(3):1011-4. PubMed ID: 17296399 [TBL] [Abstract][Full Text] [Related]
4. Experience with 100 cases treated with botulinum-A toxin injections in the detrusor muscle for idiopathic overactive bladder syndrome refractory to anticholinergics. Schmid DM; Sauermann P; Werner M; Schuessler B; Blick N; Muentener M; Strebel RT; Perucchini D; Scheiner D; Schaer G; John H; Reitz A; Hauri D; Schurch B J Urol; 2006 Jul; 176(1):177-85. PubMed ID: 16753396 [TBL] [Abstract][Full Text] [Related]
5. Treatment of axillary hyperhidrosis with botulinum toxin type A reconstituted in lidocaine or in normal saline: a randomized, side-by-side, double-blind study. Vadoud-Seyedi J; Simonart T Br J Dermatol; 2007 May; 156(5):986-9. PubMed ID: 17286630 [TBL] [Abstract][Full Text] [Related]
6. Botulinum A toxin intravesical injection in patients with painful bladder syndrome: 1-year followup. Giannantoni A; Porena M; Costantini E; Zucchi A; Mearini L; Mearini E J Urol; 2008 Mar; 179(3):1031-4. PubMed ID: 18206941 [TBL] [Abstract][Full Text] [Related]
7. Effectiveness of botulinum-A toxin for the treatment of refractory overactive bladder in children. Marte A; Borrelli M; Sabatino MD; Balzo BD; Prezioso M; Pintozzi L; Nino F; Parmeggiani P Eur J Pediatr Surg; 2010 May; 20(3):153-7. PubMed ID: 20112186 [TBL] [Abstract][Full Text] [Related]
8. Re: Efficacy and complications of intradetrusor injection with botulinum toxin A in patients with refractory idiopathic detrusor overactivity. Sahai A; Dowson C; Khan MS; Dasgupta P BJU Int; 2008 Feb; 101(4):515-6; author reply 516-7. PubMed ID: 18234066 [No Abstract] [Full Text] [Related]
9. Histological changes in the urothelium and suburothelium of human overactive bladder following intradetrusor injections of botulinum neurotoxin type A for the treatment of neurogenic or idiopathic detrusor overactivity. Apostolidis A; Jacques TS; Freeman A; Kalsi V; Popat R; Gonzales G; Datta SN; Ghazi-Noori S; Elneil S; Dasgupta P; Fowler CJ Eur Urol; 2008 Jun; 53(6):1245-53. PubMed ID: 18343564 [TBL] [Abstract][Full Text] [Related]
10. Efficacy and complications of intradetrusor injection with botulinum toxin A in patients with refractory idiopathic detrusor overactivity. Jeffery S; Fynes M; Lee F; Wang K; Williams L; Morley R BJU Int; 2007 Dec; 100(6):1302-6. PubMed ID: 17979928 [TBL] [Abstract][Full Text] [Related]
11. [Botulinum toxin type A in patients with overactive bladder]. Krivoborodov GG; Vasil'ev AV; Shumilo DV; Ivanov AV; Tur EI Urologiia; 2010; (3):36-40. PubMed ID: 20734876 [TBL] [Abstract][Full Text] [Related]
12. Short-term efficacy of botulinum toxin a for refractory overactive bladder in the elderly population. White WM; Pickens RB; Doggweiler R; Klein FA J Urol; 2008 Dec; 180(6):2522-6. PubMed ID: 18930481 [TBL] [Abstract][Full Text] [Related]
13. What a patient with refractory idiopathic detrusor overactivity should know about botulinum neurotoxin type a injection. Khan S; Kessler TM; Apostolidis A; Kalsi V; Panicker J; Roosen A; Gonzales G; Haslam C; Elneil S; Fowler CJ; Dasgupta P J Urol; 2009 Apr; 181(4):1773-8. PubMed ID: 19233414 [TBL] [Abstract][Full Text] [Related]
14. EMLA cream application without occlusive dressing before upper facial botulinum toxin injection: a randomized, double-blind, placebo-controlled trial. Kashkouli MB; Salimi S; Bakhtiari P; Parvaresh MM; Sanjari MS; Naseripour M Ann Plast Surg; 2008 Apr; 60(4):353-6. PubMed ID: 18362558 [TBL] [Abstract][Full Text] [Related]
15. A minimally invasive technique for outpatient local anaesthetic administration of intradetrusor botulinum toxin in intractable detrusor overactivity. Schulte-Baukloh H; Knispel HH BJU Int; 2005 Feb; 95(3):454. PubMed ID: 15679820 [No Abstract] [Full Text] [Related]
16. Lidocaine tape (Penles) reduces the pain of botulinum toxin injection for Meige syndrome. Onguchi T; Takano Y; Dogru M; Ono M; Tsubota K Am J Ophthalmol; 2004 Oct; 138(4):654-5. PubMed ID: 15488799 [TBL] [Abstract][Full Text] [Related]
17. Editorial comment on: histological changes in the urothelium and suburothelium of human overactive bladder following intradetrusor injections of botulinum neurotoxin type A for the treatment of neurogenic or idiopathic detrusor overactivity. Haferkamp A Eur Urol; 2008 Jun; 53(6):1253. PubMed ID: 18343561 [No Abstract] [Full Text] [Related]
18. Lack of ultrastructural detrusor changes following endoscopic injection of botulinum toxin type a in overactive neurogenic bladder. Haferkamp A; Schurch B; Reitz A; Krengel U; Grosse J; Kramer G; Schumacher S; Bastian PJ; Büttner R; Müller SC; Stöhrer M Eur Urol; 2004 Dec; 46(6):784-91. PubMed ID: 15548448 [TBL] [Abstract][Full Text] [Related]
19. Immediate versus delayed outpatient flexible cystoscopy: final report of a randomized study. Herr HW; Schneider M Can J Urol; 2001 Dec; 8(6):1406-8. PubMed ID: 11788018 [TBL] [Abstract][Full Text] [Related]
20. Botulinum toxin A injection into corrugator muscle for frontally localised chronic daily headache or chronic tension-type headache. de Ru JA; Buwalda J J Laryngol Otol; 2009 Apr; 123(4):412-7. PubMed ID: 18588738 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]